Achieving Consensus When Everyone is an Expert, but No One Agrees
•
0 likes•104 views
Experts from PHAR, Novartis, and Bausch Health give a discussion around the Delphi panels and how the results are used. For over 15 years, PHAR has conducted RAND/UCLA modified Delphi panels to obtain consensus among clinicians. During this webinar, the experts will broadly present different methods for gaining consensus including the different “Delphi panel” approaches that exist, the history of the method used, the behavioral science behind why these panels work, how these panels (both in person and virtually) are conducted, and the outcome of the panels. In addition to Dr. Michael Broder, President of PHAR’s, experience, there are two researchers (one physician and one research scientist) from the pharmaceutical industry who share their experience participating in these panels. They provide their perspective on leading these panels (including why sometimes it’s recommended they are blinded to all aspects), their experience participating in the discussions, and how they have used the results. Key Topics Include: - Overview of the different ways to obtain consensus from expert clinicians - The broad steps involved in conducting a RAND/UCLA modified Delphi panel method - The possible outcomes of such a panel - Benefits and challenges of this method
Report
Share
Report
Share
Download to read offline
Recommended
Evidence-Based HR Management & Systematic Reviews
Evidence-Based HR Management & Systematic Reviews
PhD Consortium of the 7th International Conference of the Dutch HRM network,
Rob Briner, Eric Barends
Incorporating CanMEDS in Residency Training Final 1
Activities and Ideas on Promoting a Competency-based Training Curriculum
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...CUE - Consumers United for Evidence-based Healthcare
Respond to Sherita and comment on her plans to practice self-reflect.docx
Respond to Sherita and comment on her plans to practice self-reflection. Your responses are expected to be substantive in nature and should reference the assigned readings or other professional literature, as applicable, to support your views.
Sherita post
Reflective Process
Gibbs reflective cycle offers many of the steps I find necessary to diagnose, rationalize and perceive outcomes in my decision making. It is my utilization of these 6 interests that allows me to first question an experience, associate my involvement, outline relative options, make deductions on capacity and approximate expectancies as they relate to improvement/sustainability of outcomes (EPM, 2019).
My strengths and weaknesses are correlations of one another and can often be classified as my need to utilize both clinical and statistical approaches (Ruscio, 2006).The problem is that I want to believe despite actual proof, in some methods of pseudoscience but on the other hand, I find myself critiquing various works based on merit, research and the application study *. Division of these practices can become hard when approaching both, professional and interpersonal concerns based on how the concern is derived. This in return could prove costly on a reliability front (Ruscio, 2006). Developing a governance to my approach where I can question my own work as well as they work of others while practicing the skills obtained for study and research is my ultimate goal. I feel as though our introduction into psychology has established a structure within us all that stands to improve the methods developed, utilized and appropriated. I want to be a part of a generation where I can be told that this is a misdiagnosis and be offered support in determine the correct methods of treatment. Being overconfidence has driven many of our fields research and study and must be accountable when necessary if it stands to negatively affect those treated or studied (Ruscio, 2006).
Self reflection
Remembering to evaluate myself is a good place to start given the barriers overconfidence can create in any individual (Ruscio, 2006). In many cases, perfection is not the goal but growth and improvement are acceptable. In many professions, I believe one can be bolstered by position alone and this can be dangerous to the importance to the professional and their patient's needs. Continued education and a development of periodic evaluation can help me personally understand my own development and how I can better affect the outcomes in my decisions (EPM, 2019). Remaining open to criticism and change also aids in the realization that I, too, am human and require development much like the individuals I assist.
Discussion 1
Respond to the following in a minimum of 175 words:
Consider
each of the public speaking scenarios below and
discuss
some of the factors that impact the communication process.
Public speaking to a live (in person) audience.
Given this channel (face-.
Introduction
Cochrane Review author training workshop, January 22-23, 2009 at the University of Calgary Health Sciences Centre
Consortium metrics discussion with IOM Drug Forum
Presentation made to the IOM Forum on Drug Discovery, Development, and Translation to explore the possibility of metrics that evaluate the performance of biomedical research consortia
Recommended
Evidence-Based HR Management & Systematic Reviews
Evidence-Based HR Management & Systematic Reviews
PhD Consortium of the 7th International Conference of the Dutch HRM network,
Rob Briner, Eric Barends
Incorporating CanMEDS in Residency Training Final 1
Activities and Ideas on Promoting a Competency-based Training Curriculum
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...CUE - Consumers United for Evidence-based Healthcare
Respond to Sherita and comment on her plans to practice self-reflect.docx
Respond to Sherita and comment on her plans to practice self-reflection. Your responses are expected to be substantive in nature and should reference the assigned readings or other professional literature, as applicable, to support your views.
Sherita post
Reflective Process
Gibbs reflective cycle offers many of the steps I find necessary to diagnose, rationalize and perceive outcomes in my decision making. It is my utilization of these 6 interests that allows me to first question an experience, associate my involvement, outline relative options, make deductions on capacity and approximate expectancies as they relate to improvement/sustainability of outcomes (EPM, 2019).
My strengths and weaknesses are correlations of one another and can often be classified as my need to utilize both clinical and statistical approaches (Ruscio, 2006).The problem is that I want to believe despite actual proof, in some methods of pseudoscience but on the other hand, I find myself critiquing various works based on merit, research and the application study *. Division of these practices can become hard when approaching both, professional and interpersonal concerns based on how the concern is derived. This in return could prove costly on a reliability front (Ruscio, 2006). Developing a governance to my approach where I can question my own work as well as they work of others while practicing the skills obtained for study and research is my ultimate goal. I feel as though our introduction into psychology has established a structure within us all that stands to improve the methods developed, utilized and appropriated. I want to be a part of a generation where I can be told that this is a misdiagnosis and be offered support in determine the correct methods of treatment. Being overconfidence has driven many of our fields research and study and must be accountable when necessary if it stands to negatively affect those treated or studied (Ruscio, 2006).
Self reflection
Remembering to evaluate myself is a good place to start given the barriers overconfidence can create in any individual (Ruscio, 2006). In many cases, perfection is not the goal but growth and improvement are acceptable. In many professions, I believe one can be bolstered by position alone and this can be dangerous to the importance to the professional and their patient's needs. Continued education and a development of periodic evaluation can help me personally understand my own development and how I can better affect the outcomes in my decisions (EPM, 2019). Remaining open to criticism and change also aids in the realization that I, too, am human and require development much like the individuals I assist.
Discussion 1
Respond to the following in a minimum of 175 words:
Consider
each of the public speaking scenarios below and
discuss
some of the factors that impact the communication process.
Public speaking to a live (in person) audience.
Given this channel (face-.
Introduction
Cochrane Review author training workshop, January 22-23, 2009 at the University of Calgary Health Sciences Centre
Consortium metrics discussion with IOM Drug Forum
Presentation made to the IOM Forum on Drug Discovery, Development, and Translation to explore the possibility of metrics that evaluate the performance of biomedical research consortia
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?Center for Evidence-Based Management
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?
Eric Barends
AUPHA 2013 Annual Meeting
Monterey, CAFOQUSAphasia Informational Meeting 1.22.20
Please see our website: www.foqusaphasia.com
Join our Google Group: http://bit.ly/FOQUSAphasiaGroup
DECISION MAKING7 Strategies for BetterGroup Decision-Mak
DECISION MAKING
7 Strategies for Better
Group Decision-Making
by Torben Emmerling and Duncan Rooders
SEPTEMBER 22, 2020
HBR STAFF/CHARLES DELUVIO/UNSPLASH
When you have a tough business problem to solve, you likely bring it to a group. After all, more
minds are better than one, right? Not necessarily. Larger pools of knowledge are by no means a
guarantee of better outcomes. Because of an over-reliance on hierarchy, an instinct to prevent
dissent, and a desire to preserve harmony, many groups fall into groupthink.
Misconceived expert opinions can quickly distort a group decision. Individual biases can easily
spread across the group and lead to outcomes far outside individual preferences. And most of these
processes occur subconsciously.
2COPYRIGHT © 2020 HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION. ALL RIGHTS RESERVED.
http://williamwolff.org/wp-content/uploads/2016/01/griffin-groupthink-challenger.pdf
This doesn’t mean that groups shouldn’t make decisions together, but you do need to create the right
process for doing so. Based on behavioral and decision science research and years of application
experience, we have identified seven simple strategies for more effective group decision making:
Keep the group small when you need to make an important decision. Large groups are much more
likely to make biased decisions. For example, research shows that groups with seven or more
members are more susceptible to confirmation bias. The larger the group, the greater the tendency
for its members to research and evaluate information in a way that is consistent with pre-existing
information and beliefs. By keeping the group to between three and five people, a size that people
naturally gravitate toward when interacting, you can reduce these negative effects while still
benefitting from multiple perspectives.
Choose a heterogenous group over a homogenous one (most of the time). Various studies have
found that groups consisting of individuals with homogeneous opinions and beliefs have a greater
tendency toward biased decision making. Teams that have potentially opposing points of view can
more effectively counter biases. However, context matters. When trying to complete complex tasks
that require diverse skills and perspectives, such as conducting research and designing processes,
heterogeneous groups may substantially outperform homogeneous ones. But in repetitive tasks,
requiring convergent thinking in structured environments, such as adhering to safety procedures in
flying or healthcare, homogenous groups often do better. As a leader, you need first to understand
the nature of the decision you’re asking the group to make before you assemble a suitable team.
Appoint a strategic dissenter (or even two). One way to counter undesirable groupthink tendencies
in teams is to appoint a “devil’s advocate.” This person is tasked with acting as a counterforce to the
group’s consensus. Research shows that empowering at least one person with the right to ...
Sacnas 2009 Networking Workshop Thursday Lunch
Thursday lunch 10 minute talk on the fundamentals of networking.
2.29.2012 Obesity Integration Steering Committee Presentation
CO Department of Public Health and Environment, Prevention Services Division Obesity Integration Steering Committee Presentation
Formulando recomendaciones implementables
"Formulando recomendaciones implementables" presentación realizada por por Andrew D. Oxman, investigador del Norwegian Institute of Public Health en las Jornadas Científicas de GuíaSalud (Madrid, 4 abril 2016)
Journal Clubs for Professional Development
Understanding the concept of a journal club, why to choose it as a CPD activity and how to set it up
Obstetric referral in cambodia what works - 2014 presentation
Presentation on ReBUILD Responsive Fund project Obstetric referral in Cambodia - What works? Given at project half-way stage.
Does executive coaching work? The questions every coach needs to ask and (at ...
Does executive coaching work? The questions every coach needs to ask and (at ...Center for Evidence-Based Management
Does executive coaching work? The questions every coach needs to ask and (at least try to) answer.
Rob Briner
January 9th 2013
DOP Annual Conference, Chester, UK
Anthony Presentation DIA Florida Ctd Nov2007
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
Factors influencing researchers' skill development process
This is mainly for Pharma R&D but the principles apply to all specialities.
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
Presentation given at CBI 3rd Annual Forum on Oncology Commercialization Strategies [Philadelphia, Jan 21, 2010]
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Tra...
Join Prof. Victoria Hutter and Dr. Louis Scott as they showcase the application of high-content imaging and advanced cell lines for drug safety assessment.
Safety concerns play a significant role in the unsuccessful progression of candidate compounds in the later stages of drug development. Establishing the connection between in vitro endpoints and human health outcomes is essential.
In this webinar, Prof. Victoria Hutter and Dr. Louis Scott present a novel tool for in vitro safety assessment in drug development. The morph_ONE™ assay provides a human-centric approach to potentially fill specific regulatory gaps concerning safety issues. This tool is capable of profiling both human and rat alveolar macrophages, offering valuable insights for hazard identification and toxicity assessments. By bridging the divide between cellular effects and overall risk, it has the potential to enhance our understanding of safety-related aspects in drug development.
Key Topics Include:
- Explore distinct in vitro screening techniques for evaluating the safety of emerging inhaled products, facilitating early and informed decisions in compound selection and development.
- How high-content image analysis (HCIA) cell painting assays can be used as a forward-looking high-throughput screening tool, distinguishing unique response patterns in alveolar macrophages.
- Understand the use of the ImmuPHAGE™ and ImmuLUNG™ models in conducting customized evaluations focused on inhalation safety.
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cance...
In this webinar, Aditya Pratapa and Lorcan Sherry present a new workflow for analyzing multiplex immunoflurescence images.
Spatial Signatures are a new class of highly predictive biomarkers that measure the interactions and cellular densities of tumor and immune cells that compose the tumor microenvironment. Based on multiplex immunofluorescence, spatial signatures provide a deeper understanding of complex interactions between tumors and the immune system, enabling improved patient stratification for immunotherapies. A significant hurdle to date has been in developing a data analysis workflow that is straightforward and user-friendly to transform the data rich images into meaningful quantitative spatial signatures.
In this webinar, Aditya and Lorcan review the key features of the new PhenoImager HT 2.0 data analysis workflow. This workflow introduces a simplified framework from scanning to analyzing spectrally unmixed multiplex immunofluorescence images generated on the PhenoImager HT platform. The ready-to-analyze data can be directly imported into image analysis software such as Visiopharm. This presentation covers key aspects of data analysis elements such as image QC, segmentation, phenotyping, and verification – all essential for creating outputs that support the development of a spatial signature.
Key Topics Include:
- Understand Akoya’s new HT 2.0 data analysis workflow
- The challenges in multiplex immunofluorescence analysis and the use of AI and cell
lineage segmentation considerations
- Explore OracleBio’s image analysis workflow incorporating Visiopharm
- Evaluation of analysis data to facilitate spatial profiling and interpretation
More Related Content
Similar to Achieving Consensus When Everyone is an Expert, but No One Agrees
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?Center for Evidence-Based Management
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?
Eric Barends
AUPHA 2013 Annual Meeting
Monterey, CAFOQUSAphasia Informational Meeting 1.22.20
Please see our website: www.foqusaphasia.com
Join our Google Group: http://bit.ly/FOQUSAphasiaGroup
DECISION MAKING7 Strategies for BetterGroup Decision-Mak
DECISION MAKING
7 Strategies for Better
Group Decision-Making
by Torben Emmerling and Duncan Rooders
SEPTEMBER 22, 2020
HBR STAFF/CHARLES DELUVIO/UNSPLASH
When you have a tough business problem to solve, you likely bring it to a group. After all, more
minds are better than one, right? Not necessarily. Larger pools of knowledge are by no means a
guarantee of better outcomes. Because of an over-reliance on hierarchy, an instinct to prevent
dissent, and a desire to preserve harmony, many groups fall into groupthink.
Misconceived expert opinions can quickly distort a group decision. Individual biases can easily
spread across the group and lead to outcomes far outside individual preferences. And most of these
processes occur subconsciously.
2COPYRIGHT © 2020 HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION. ALL RIGHTS RESERVED.
http://williamwolff.org/wp-content/uploads/2016/01/griffin-groupthink-challenger.pdf
This doesn’t mean that groups shouldn’t make decisions together, but you do need to create the right
process for doing so. Based on behavioral and decision science research and years of application
experience, we have identified seven simple strategies for more effective group decision making:
Keep the group small when you need to make an important decision. Large groups are much more
likely to make biased decisions. For example, research shows that groups with seven or more
members are more susceptible to confirmation bias. The larger the group, the greater the tendency
for its members to research and evaluate information in a way that is consistent with pre-existing
information and beliefs. By keeping the group to between three and five people, a size that people
naturally gravitate toward when interacting, you can reduce these negative effects while still
benefitting from multiple perspectives.
Choose a heterogenous group over a homogenous one (most of the time). Various studies have
found that groups consisting of individuals with homogeneous opinions and beliefs have a greater
tendency toward biased decision making. Teams that have potentially opposing points of view can
more effectively counter biases. However, context matters. When trying to complete complex tasks
that require diverse skills and perspectives, such as conducting research and designing processes,
heterogeneous groups may substantially outperform homogeneous ones. But in repetitive tasks,
requiring convergent thinking in structured environments, such as adhering to safety procedures in
flying or healthcare, homogenous groups often do better. As a leader, you need first to understand
the nature of the decision you’re asking the group to make before you assemble a suitable team.
Appoint a strategic dissenter (or even two). One way to counter undesirable groupthink tendencies
in teams is to appoint a “devil’s advocate.” This person is tasked with acting as a counterforce to the
group’s consensus. Research shows that empowering at least one person with the right to ...
Sacnas 2009 Networking Workshop Thursday Lunch
Thursday lunch 10 minute talk on the fundamentals of networking.
2.29.2012 Obesity Integration Steering Committee Presentation
CO Department of Public Health and Environment, Prevention Services Division Obesity Integration Steering Committee Presentation
Formulando recomendaciones implementables
"Formulando recomendaciones implementables" presentación realizada por por Andrew D. Oxman, investigador del Norwegian Institute of Public Health en las Jornadas Científicas de GuíaSalud (Madrid, 4 abril 2016)
Journal Clubs for Professional Development
Understanding the concept of a journal club, why to choose it as a CPD activity and how to set it up
Obstetric referral in cambodia what works - 2014 presentation
Presentation on ReBUILD Responsive Fund project Obstetric referral in Cambodia - What works? Given at project half-way stage.
Does executive coaching work? The questions every coach needs to ask and (at ...
Does executive coaching work? The questions every coach needs to ask and (at ...Center for Evidence-Based Management
Does executive coaching work? The questions every coach needs to ask and (at least try to) answer.
Rob Briner
January 9th 2013
DOP Annual Conference, Chester, UK
Anthony Presentation DIA Florida Ctd Nov2007
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
Factors influencing researchers' skill development process
This is mainly for Pharma R&D but the principles apply to all specialities.
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
Presentation given at CBI 3rd Annual Forum on Oncology Commercialization Strategies [Philadelphia, Jan 21, 2010]
Similar to Achieving Consensus When Everyone is an Expert, but No One Agrees (20)
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?
Evidence-Based Practice: If Doctors Can Do It, Managers Can Do It?
DECISION MAKING7 Strategies for BetterGroup Decision-Mak
DECISION MAKING7 Strategies for BetterGroup Decision-Mak
2.29.2012 Obesity Integration Steering Committee Presentation
2.29.2012 Obesity Integration Steering Committee Presentation
Leading virtual teams .HUDSON Research & Consulting
Leading virtual teams .HUDSON Research & Consulting
Obstetric referral in cambodia what works - 2014 presentation
Obstetric referral in cambodia what works - 2014 presentation
Does executive coaching work? The questions every coach needs to ask and (at ...
Does executive coaching work? The questions every coach needs to ask and (at ...
Factors influencing researchers' skill development process
Factors influencing researchers' skill development process
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
More from InsideScientific
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Tra...
Join Prof. Victoria Hutter and Dr. Louis Scott as they showcase the application of high-content imaging and advanced cell lines for drug safety assessment.
Safety concerns play a significant role in the unsuccessful progression of candidate compounds in the later stages of drug development. Establishing the connection between in vitro endpoints and human health outcomes is essential.
In this webinar, Prof. Victoria Hutter and Dr. Louis Scott present a novel tool for in vitro safety assessment in drug development. The morph_ONE™ assay provides a human-centric approach to potentially fill specific regulatory gaps concerning safety issues. This tool is capable of profiling both human and rat alveolar macrophages, offering valuable insights for hazard identification and toxicity assessments. By bridging the divide between cellular effects and overall risk, it has the potential to enhance our understanding of safety-related aspects in drug development.
Key Topics Include:
- Explore distinct in vitro screening techniques for evaluating the safety of emerging inhaled products, facilitating early and informed decisions in compound selection and development.
- How high-content image analysis (HCIA) cell painting assays can be used as a forward-looking high-throughput screening tool, distinguishing unique response patterns in alveolar macrophages.
- Understand the use of the ImmuPHAGE™ and ImmuLUNG™ models in conducting customized evaluations focused on inhalation safety.
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cance...
In this webinar, Aditya Pratapa and Lorcan Sherry present a new workflow for analyzing multiplex immunoflurescence images.
Spatial Signatures are a new class of highly predictive biomarkers that measure the interactions and cellular densities of tumor and immune cells that compose the tumor microenvironment. Based on multiplex immunofluorescence, spatial signatures provide a deeper understanding of complex interactions between tumors and the immune system, enabling improved patient stratification for immunotherapies. A significant hurdle to date has been in developing a data analysis workflow that is straightforward and user-friendly to transform the data rich images into meaningful quantitative spatial signatures.
In this webinar, Aditya and Lorcan review the key features of the new PhenoImager HT 2.0 data analysis workflow. This workflow introduces a simplified framework from scanning to analyzing spectrally unmixed multiplex immunofluorescence images generated on the PhenoImager HT platform. The ready-to-analyze data can be directly imported into image analysis software such as Visiopharm. This presentation covers key aspects of data analysis elements such as image QC, segmentation, phenotyping, and verification – all essential for creating outputs that support the development of a spatial signature.
Key Topics Include:
- Understand Akoya’s new HT 2.0 data analysis workflow
- The challenges in multiplex immunofluorescence analysis and the use of AI and cell
lineage segmentation considerations
- Explore OracleBio’s image analysis workflow incorporating Visiopharm
- Evaluation of analysis data to facilitate spatial profiling and interpretation
Molecule Transport across Cell Membranes: Electrochemical Quantification at t...
In this webinar, Dr. Sabine Kuss will discuss the importance of transmembrane molecule exchange and how to detect and quantify membrane transport of molecules in cells.
Complex biological processes, such as the transport of molecules across cell membranes, are difficult to understand using purely biological methodologies. Investigating cellular transport processes is challenging, because of the highly complex chemical composition of cells and the diffusion of molecules in and around cells at low concentrations. The development and advancement of electroanalytical methods over the last two decades has enabled the monitoring of living cells and their interaction with the environment, including external stimuli, such as pharma-molecules.
This presentation emphasizes electrochemical and electrophysiological methods of detection and quantification but also makes a comparison to other bioanalytical approaches. Join us to discover a substantial diversity in methods used to monitor the transport of cell metabolites, crucial for cell survival, and pharmaceutical compounds, involved in cell characteristics such as drug resistance.
Key Topics Include:
- Understanding transmembrane molecule transport through bioanalytical methods
- Electrochemical approaches to monitor molecule transport across cell membranes
- What bioanalytical and especially electrochemical approaches can reveal
- Challenges associated with instrument limitations
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in ...
In this webinar, Dr. Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.
Recurrent glioblastoma (rGBM) has displayed a varied response to anti-PD-1 immunotherapy, necessitating the identification of predictive biomarkers. Through extensive analyses and 3 clinical studies, we have identified that activation of the MAPK/ERK signaling pathway, particularly ERK1/2 phosphorylation (p-ERK), is associated with longer overall survival (OS) in rGBM patients receiving PD-1 blockade. Initially, enrichment of BRAF/PTPN11 mutations was reported in 30% of responsive rGBM patients, prompting the investigation of p-ERK as a potential marker beyond these mutations.
Our research has unraveled an association between p-ERK abundance and better clinical outcomes following PD-1 blockade, with p-ERK mainly localized in tumor cells. Notably, high p-ERK GBMs contained unique microglia and macrophage phenotypes with elevated MHC class II expression, suggesting a novel interplay between MAPK activation and the tumor immune microenvironment.
While these insights establish a pivotal role for p-ERK in predicting PD-1 blockade response in rGBM, the implementation in clinical settings calls for further validation and accuracy. Nonetheless, these findings pave the way for more personalized and effective immunotherapy strategies, emphasizing the significance of the tumor microenvironment and its interaction with therapeutic interventions in GBM.
Key Topics Include:
- The activation of the MAPK signaling pathway, specifically ERK1/2 phosphorylation (p-ERK), is identified as a predictive biomarker for longer overall survival in recurrent glioblastoma (eGBM) patients undergoing PD-1 blockade
- High p-ERK tumors in rGBM present a distinct myeloid cell phenotype with elevated MHC class II expression, signifying a connection between MAPK pathway activation and the immune microenvironment
- The implementation of p-ERK as a predictive biomarker in clinical settings requires further validation and exploration of variables impacting its evaluation
Exploring Estrogen’s Role in Metabolism and the Use of 13C-Labeled Nutrients ...
Dr. Reilly Enos and Dr. Eran Levin discuss estrogen's metabolic impact and how isotopic labeling and 13C-labeled nutrients can be used for animal physiology and nutrition research.
Reilly Enos, PhD – Harnessing the power of estrogen to regulate metabolic processes
Dr. Reilly Enos’ research focuses on the role that sex steroids and their receptors play in regulating metabolic processes, particularly in the setting of obesity. In this webinar, Dr. Enos will discuss his research on tissue-specific fluctuations of sex steroids throughout the estrous cycle in mice, provide insights into the importance of the quantity of estrogen necessary to impact physiological processes, as well as an understanding of the central versus peripheral effects of estrogen action.
Eran Levin, PhD – Unlocking Insights: Utilizing 13C Labeled Nutrients for Cutting-Edge Physiology and Nutrition Research
Dr. Eran Levin will discuss the potential of using 13C-labeled nutrients in physiology and nutrition research in animal models. Specifically, he will share practical tips for designing and conducting experiments using isotopic labeling techniques and demonstrate how they can provide unprecedented insights into metabolic pathways, nutrient utilization, and behaviors in both vertebrate and invertebrate models including insects, reptiles, and mammals.
Key Topics Include:
- The role that estrogen plays in regulating metabolic and behavioral processes in males and females
- The tissue-specific fluctuations of sex steroids throughout the estrous cycle
- Insight into the importance of tissue-specificity in developing hormonal therapies
- The importance of estrogen quantity in regulating physiological processes
- Understand the diverse range of 13C labeled nutrients available
- Specific applications of labeled amino acids in studies of protein metabolism, cellular signaling, and typical nutrient utilization
- How to integrate 13C labeling techniques with respirometry for a comprehensive assessment of metabolic processes, energy expenditure, and substrate utilization in animal models
- How to calculate metabolic rates in free-flying animals using 13C bicarbonate
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
Experts present a cell-free plasma biobank and describe the role of longitudinal plasma samples for cancer research, disease monitoring, and biomarker development.
Through liquid biopsies, it is now possible to repeatedly and non-invasively interrogate the molecular landscape of solid tumors via a blood draw over the whole treatment course. Until now, liquid biopsies can be used for screening, disease monitoring and prognosis. Circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) have been the most explored targets in this technology for commercial applications up to the present time.
In collaboration with a continuously expanding oncology network, Indivumed Services has established a unique high-quality cell-free plasma biobank that is exclusively focused on collecting longitudinal whole blood samples from cancer patients. This allows molecular insight by providing quick access to longitudinal plasma from cancer patients that have undergone treatment. ctDNA can then be isolated from longitudinal cell-free plasma to allow for monitoring of disease progression by providing diagnostic and prognostic information, potentially in real time.
Key Topics Include:
- Gain insights into Indivumed Services’ longitudinal plasma collection process
- Understand the advantages and benefits of utilizing longitudinal plasma samples for cancer research
- Explore applications of longitudinal plasma samples for biomarker research and development of companion diagnostics
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line an...
In this webinar, experts present a standardized stem cell line and its differentiation into neural cells for disease modeling and assay development.
Reproducible research with human induced pluripotent stem cells (iPSCs) depends on thoroughly characterized and quality-controlled cell lines. In this webinar, Dr. Andrew Gaffney and Dr. Erin Knock from STEMCELL Technologies describe the generation of a standardized induced pluripotent stem cell (iPSC) line. Developed with the upcoming ISSCR Standards Initiative characterization guidelines in mind, this highly characterized line is karyotypically stable, demonstrates trilineage differentiation potential, and expresses undifferentiated cell markers. Further, STEMCELL has developed a highly pure, ready-to-use neural progenitor cell product expressing PAX6 and SOX1 over multiple passages.
Dr. Knock shows how these multipotent cells are suitable for customized downstream differentiation to various CNS cell types, such as forebrain neurons, midbrain neurons, and astrocytes. These progenitor cells are the ideal controls for standardizing downstream differentiation protocols, modeling diseases, and assay development.
Key Topics Include:
- Discover how STEMCELL’s induced pluripotent stem cell lines are derived and characterized
- Learn how to differentiate induced pluripotent stem cell lines into all three germ layers
- Explore the features of STEMCELL’s neural progenitor cell product
- Differentiate neural progenitor cells into a variety of neural cell types, including neurons and glia
How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow's Cell Ther...
Ian Foster and Steven Loo-Yong-Kee discuss Artisan Bio's STAR-CRISPR system for optimized gene editing in cell therapy, with a focus on the genetifc modification of T cells for cancer immunotherapy.
Cell therapy is an emerging field with great promise for the treatment of various diseases. One of the most exciting areas of cell therapy is the use of T cells that have been genetically modified to recognize and kill cancer cells. While the use of T cells for cancer immunotherapy has tremendous promise, there is still room for improvement. The efficiency, expansion, and functionality of T cells can be enhanced by genetic modification using the STAR-CRISPR system.
Artisan Bio is a biotechnology company focused on developing a CRISPR-mediated editing platform to improve the efficacy and safety of cell therapy products. In this webinar, we will provide a comprehensive overview of Artisan Bio’s STAR-CRISPR system, which is designed to improve the specificity and efficiency of gene editing for cell therapies. We will explain the system’s key components and how we are using a risk-based approach to optimize and validate the editing platform. The webinar will focus on Artisan Bio’s approach to building T cell OS/APPS through iterative improvements to achieve best-in-class editing capabilities and improved cell health metrics.
Key Topics Include:
- Learn about Artisan Bio’s proprietary high-performance STAR-CRISPR system for improving the specificity and efficiency of gene editing for cell therapies
- Explore Artisan Bio’s risk-based, systems approach to technology development, including how to implement Design of Experiments (DoE) and Quality by Design (QbD) principles to optimize and validate any process
- Case study of the application of QbD to Artisan Bio’s STAR-CRISPR platform to edit T cells for cancer immunotherapy with preliminary data showing improved efficacy, expansion, and functionality
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Dr. Bert Bond and Max Weston will present an overview on their study investigating the effects high-intensity interval exercise has on cerebrovascular health.
Physical activity reduces the risk of developing cardiovascular diseases (CVD) and dementia. This benefit cannot be explained by changes in traditional CVD risk factors alone, and direct improvements in vascular health are thought to play a key role. However, our understanding of how exercise can be optimized for improvements in blood-vessel health is limited.
High-intensity interval exercise (HIIE) is known to improve peripheral vascular function, and there is a growing interest in the effects of HIIE on cerebrovascular health. However, it is not clear whether the acute improvements in peripheral vascular function following HIIE are also seen in the major blood-vessels of the brain.
In the Bond lab’s study, 30 minutes of HIIE completed at both 75% and 90% V̇O2max improved peripheral vascular function 1 and 3h following exercise in healthy young adults, compared with work-matched continuous moderate-intensity exercise and a sedentary control condition. By contrast, cerebrovascular function was unchanged following all conditions. This is the first study to identify that acute improvements in peripheral vascular function following high-intensity interval exercise are not mirrored by improvements in cerebrovascular function in healthy young adults.
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Dr. Sam Sternberg discusses a novel CRISPR-Cas9 system using programmable, RNA-guided transposase, and highlights its implications for kilobase-scale genome engineering in cell and gene therapies.
The utility of programmable, RNA-guided CRISPR-Cas systems in genome engineering continues to evolve. Nature has afforded scientists novel and diverse gene editing functionality, from nuclease-dependent CRISPR-Cas9 to second-generation base and prime editors that do not produce double-strand breaks.
In this webinar, Dr. Sam Sternberg describes a new CRISPR-Cas9 paradigm relying on nuclease-deficient bacterial transposons that catalyze RNA-guided integration of mobile genetic elements into the genome. The discovery of a fully programmable, RNA-guided transposase lays the foundation for kilobase-scale genome engineering with broad applications for developing cell and gene therapies.
Key Topics Include:
- The basics of first- and second-generation CRISPR-Cas technologies from a scientist at the forefront of their development
- Mechanisms, accommodation, and cell type diversity of CRISPR-Cas programmable transposition
- How transposase factor coordination enables highly specific, genome-wide DNA integration to target sites
- Implications of programmable transposases that obviate the need for DNA double-strand breaks and homologous recombination
Simple Tips to Significantly Improve Rodent Surgical Outcomes
Dr. Marcel Perret-Gentil presents six simple-to-implement techniques to significantly improve surgical outcomes.
You may feel proficient, even confident in performing rodent surgery; however, you may be surprised how simple improvements can have a huge impact to your animal’s recovery and data. The presentation is designed for individuals who have minimal or no rodent surgical skills but is also a great opportunity for those with considerable experience wanting to improve outcomes as well as teach such key principles.
Key Topics Include:
- Improve surgical outcomes that will lessen post-op morbidity and mortality
- Improve data yield after rodent surgery
- Implementation of key principles into a rodent surgical program
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
A world-wide spread of the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has triggered a pandemic and generated over 600 million reported cases around the globe. A substantial portion of patients who suffered Corona Virus Disease 2019 (COVID-19) have not recovered completely but continue to experience lingering symptoms for months to years. This novel clinical syndrome has been termed Long COVID or Post-acute Sequalae of COVID-19 (PASC).
Observational studies have indicated that in about one third of cases PASC can be associated with cardiovascular (CV) autonomic dysfunction including postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, orthostatic hypotension, reflex syncope and microvascular dysfunction. The presence of CV autonomic dysfunction in PASC is important to detect since although frequently overlooked, it may be effectively treated in contrast to many other Long COVID-related symptoms.
This webinar highlights CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. Since the 1980s, genetic manipulation has allowed researchers to tailor cell lines to the experiment or production purpose. Over time, the requirements for these cell lies have risen. In many cases, the cells require multiple genetic edits and must produce data that passes FDA. Moreover, the current funding environment often requires rapid delivery of these cells so scientists can produce data to support further budget and/or investment. This is particularly acute for knock-in cell lines. Current technologies may take months to complete a cell line, allow a limited number of edits, and often have off-target effects that are not suitable for FDA filings. ExpressCells uses its patented FAST-HDR plasmid--along with CRISPR, to address these problems. The FAST-HDR process can precisely knock-in multiple genes (while supporting other types of genetic modifications), ensure precise placement of these edits, and deliver them months faster than competing technologies.
This webinar will discuss the basis of the FAST-HDR technology and illustrate several uses. The first part is a presentation by Oscar Perez-Leal, MD, the inventor of the technology. Oscar will discuss the problems he faced as a researcher and how FAST-HDR was designed to address them. He will outline the details of the technology, the history of its development, and several examples where he used FAST-HDR. The second part is a conversation with Jon Weidanz, PhD. Jon will outline the challenges he faced at AbeXXa and how he selected a FAST-HDR custom cell line for his project. He'll outline the learnings from using this cell line, some of which were unexpected, but valuable to future development.
By attending this program, attendees will:
- Understand the current challenges in creating custom gene-edited cell lines
- Know the technology underlying the FAST-HDR gene-editing system, including its use with CRISPR
- Be able to describe the advantages of the FAST-HDR system
- Learn about several case studies using gene-edited cell lines
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Watch Dr. Sarah Greising discuss the current pathophysiologic understanding of the skeletal muscle remaining following traumatic musculoskeletal injuries.
Volumetric muscle loss (VML) injuries result in the abrupt loss of skeletal muscle fibers, causing chronic functional disability in part due to limited muscle regeneration and vast co-morbidities. With a focus on clinically relevant outcome measurements for skeletal muscle function in both small and large animal models of VML injury, this webinar presents various near-term interventions for the restoration of tissue function following complex injuries. Interventions evaluated focus on regenerative rehabilitation approaches using regenerative pharmaceuticals to correct underlying muscle pathophysiology.
Designing Causal Inference Studies Using Real-World Data
In this webinar, experts provide an overview of causal inference, along with step-by-step guidance to designing these studies using real-world healthcare data.
Causal inference is used to answer cause and effect research questions and yield estimates of effect. Causal study design considerations and statistical methods address the effects of confounding variables and other potential biases and allow researchers to answer questions such as, “Does treatment A produce better patient outcomes compared to Treatment B?”
Causal study interpretations have traditionally been restricted to randomized controlled trials; however, causal inference applied to observational healthcare data is growing in importance, driven by the need for generalizable and rapidly delivered real-world evidence to inform regulatory, payer, and patient/provider decision making. The application of causal inference methods leads to stronger and more powerful evidence. When these techniques are applied to observational data, the results generated are both from and for the real world.
Presenters walk through several real-world case studies including the PCORI-funded BESTMED study and a collaborative study with a prominent pharmacy payer.
Social Media Data: Opportunities and Insights for Clinical Research
Many new data are emerging in recent years - real time data is collected through digital health technologies, including apps and wearables, monitoring data, social media data, public datasets, and patient organization data, in addition to primary and secondary datasets.
Real life data are highly informative and can be used to address a range of challenges throughout the product life cycle. Data from social media can generate valuable insights as patients often gather in digital communities to get answers and share their experiences. Conversations on social networks merit special consideration as they can have real world influence over treatment management decisions.
Social media data can reveal the motivations that impact patient healthcare decisions and behaviors through each stage of the care pathway. These data provide both the patient and caregiver perspectives at the same time. For this reason, conversations on social networks offer an opportunity to deepen our understanding on:
- The fears and hopes associated with patient treatments
- Daily needs and difficulties patients are facing in managing their disease
- The impact of disease on patient health related quality of life
- Identification in real life of the stages of the care pathway and patient perceptions
- Reactions to health policies
Watch this webinar for insights on how to collect, use, analyze, and interpret social media data in different contexts. Our experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
To learn more visit: https://insidescientific.com/webinar/we-are-more-than-what-we-eat-dietary-interventions-depend-on-sex-and-genetic-background/
Despite evidence that sex and genetic background are key factors in the response to diet, most studies of how diet regulates metabolic health and even longevity in mice examine only a single strain and sex.
Using multiple strains and both male and female mice, Dr Lamming's team has found that improvements in metabolic health and in longevity in response to reduced levels of protein or specific amino acids strongly depend on sex and strain. While some phenotypes were conserved across strains and sexes, including increased glucose tolerance and energy expenditure, they observed high variability in adiposity, insulin sensitivity, and circulating hormones. Using a multi-omics approach, they identified mega-clusters of differentially expressed hepatic genes, metabolites, and lipids associated with each phenotype, gaining new insight into role of the energy balance hormone FG21 in the response to protein restriction.
Antibody Discovery by Single B Cell Screening on Beacon®
Amy Sheng, PhD provides an overview of antibody screening platforms and presents applications and case studies using the Beacon® platform for antibody discovery.
Single B cell screening is a powerful and efficient strategy for generating antigen-specific monoclonal antibodies. Distinguished with fluorescence-activated B cell sorting, the Beacon® platform is based on plasma cell screening, making it easier to obtain antibody genes.
The Beacon® single-cell optofluidic system combines a unique optoelectro positioning (OEP) technology with novel microfluidic technology. It can be used to accurately select single cells on a chip, perform multiple single-cell assays, and export target cells based on specific results. The Beacon® optofluidic platform preserves the diversity of B cells, generating high-quality positive hits at an early stage of discovery and avoiding the loss of “good clones”.
Key Topics Include:
- B cell differentiation and development
- Pros and cons of mainstream antibody screening platforms
- Mechanisms, applications, and case studies using the Beacon® platform for antibody screening
- Sino Biological’s capacity using the Beacon® platform
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Phil Griffiths, PhD, presents a summary of chronic cardiovascular telemetry studies and considerations for experimental design.
Ensuring you collect the best and most physiologically accurate data from your chronic telemetry experiments requires careful planning and experimental design. This webinar will give an insight into the practical aspects of designing chronic animal experiments to set you on the best path for success. The benefits of chronic studies, how to select the most appropriate sample size for your study, some basic tips and tricks for data acquisition and handling, and how to ensure high animal welfare are discussed.
Key Topics Include:
- What are the benefits of chronic over acute studies?
- How to decide the best sample sizes and the length of experiments?
- Basic tips for data acquisition and handling
- How to maintain high animal welfare standards
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
In this webinar, Dr. Dennis Turner delves into dementia syndrome, the metabolic changes that occur, and the importance of proper physiological monitoring of animal models.
Brain metabolism transforms with normal aging, and transient, dynamic metabolic insufficiency may underlie critical progression from aging into dementia syndrome and Alzheimer’s disease (AD). Age-related brain metabolism balances vascular-related substrate supply and transport mechanisms into extracellular space to neurons with cellular metabolic needs and utilization. Dynamic metabolic insufficiency can occur when there is intermittent supply-demand mismatch.
Adequacy of neurovascular coupling to provide sufficient cerebral blood flow (CBF) to meet neuronal demand in vivo in a mouse AD model, compared to aged controls were studied. Dr. Turner’s lab analyzed the response to maximal neuronal metabolic demands, spreading depression and anoxia, using imaging, CBF measurements, and oxygen and glucose levels. These in vivo studies require human-similar anesthesia conditions, through monitoring temperature, blood pressure/pulse oximetry, and respiration, to maintain homeostasis. The lab confirmed abnormal neurovascular coupling in a mouse model of AD in response to these metabolic challenges, showing disruption much earlier in dementia than in equivalently aged individuals. Chronic metabolic treatments could influence dementia syndrome progression.
More from InsideScientific (20)
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Tra...
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Tra...
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cance...
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cance...
Molecule Transport across Cell Membranes: Electrochemical Quantification at t...
Molecule Transport across Cell Membranes: Electrochemical Quantification at t...
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in ...
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in ...
Exploring Estrogen’s Role in Metabolism and the Use of 13C-Labeled Nutrients ...
Exploring Estrogen’s Role in Metabolism and the Use of 13C-Labeled Nutrients ...
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line an...
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line an...
How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow's Cell Ther...
How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow's Cell Ther...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Simple Tips to Significantly Improve Rodent Surgical Outcomes
Simple Tips to Significantly Improve Rodent Surgical Outcomes
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Designing Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World Data
Social Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical Research
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
Antibody Discovery by Single B Cell Screening on Beacon®
Antibody Discovery by Single B Cell Screening on Beacon®
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Recently uploaded
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版纸张【微信：741003700 】【(carleton毕业证书)卡尔顿大学毕业证】【微信：741003700 】学位证，留信认证（真实可查，永久存档）offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原海外各大学 Bachelor Diploma degree, Master Degree Diploma
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
Phenomics assisted breeding in crop improvement
As the population is increasing and will reach about 9 billion upto 2050. Also due to climate change, it is difficult to meet the food requirement of such a large population. Facing the challenges presented by resource shortages, climate
change, and increasing global population, crop yield and quality need to be improved in a sustainable way over the coming decades. Genetic improvement by breeding is the best way to increase crop productivity. With the rapid progression of functional
genomics, an increasing number of crop genomes have been sequenced and dozens of genes influencing key agronomic traits have been identified. However, current genome sequence information has not been adequately exploited for understanding
the complex characteristics of multiple gene, owing to a lack of crop phenotypic data. Efficient, automatic, and accurate technologies and platforms that can capture phenotypic data that can
be linked to genomics information for crop improvement at all growth stages have become as important as genotyping. Thus,
high-throughput phenotyping has become the major bottleneck restricting crop breeding. Plant phenomics has been defined as the high-throughput, accurate acquisition and analysis of multi-dimensional phenotypes
during crop growing stages at the organism level, including the cell, tissue, organ, individual plant, plot, and field levels. With the rapid development of novel sensors, imaging technology,
and analysis methods, numerous infrastructure platforms have been developed for phenotyping.
Seminar of U.V. Spectroscopy by SAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
I Introduction
II Subalternation and Theology
III Theology and Dogmatic Declarations
IV The Mixed Principles of Theology
V Virtual Revelation: The Unity of Theology
VI Theology as a Natural Science
VII Theology’s Certitude
VIII Conclusion
Notes
Bibliography
All the contents are fully attributable to the author, Doctor Victor Salas. Should you wish to get this text republished, get in touch with the author or the editorial committee of the Studia Poinsotiana. Insofar as possible, we will be happy to broker your contact.
ESR spectroscopy in liquid food and beverages.pptx
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Nutraceutical market, scope and growth: Herbal drug technology
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
What is greenhouse gasses and how many gasses are there to affect the Earth.
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
SAR of Medicinal Chemistry 1st by dk.pdf
In this presentation include the prototype drug SAR on thus or with their examples .
Syllabus of Second Year B. Pharmacy
2019 PATTERN.
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityUniversity of Rennes, INSA Rennes, Inria/IRISA, CNRS
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Nucleic Acid-its structural and functional complexity.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Recently uploaded (20)
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Achieving Consensus When Everyone is an Expert, but No One Agrees
- 1. Copyright 2022. All Rights Reserved. Contact Presenter for Permission Achieving Consensus When Everyone is an Expert, but No One Agrees George Joseph, BPharm, MS, PhD Vice President Health Economics & Outcomes Research Bausch Health Michael Broder, MD, MSHS President PHAR Jincy Paulose, MD Executive Medical Director & Team Lead for Non-Malignant Hematology Novartis Pharmaceuticals
- 3. Clinical Experience Highly Trained Staff Methodologic Rigor
- 5. What do we mean by “expert panels?” Structured consensus method That brings together multidisciplinary experts With the goal of achieving consensus on topics that do not yet have strong empirical evidence Not ad boards, unstructured discussion, literature/evidence review only
- 6. Examples of expert panel methods RAND/UCLA modified Delphi panel Nominal group process GRADE approach Delphi technique Consensus development panel NCCN guidelines development BOGSAT
- 7. Discuss ratings during in-person (or virtual) meeting Review literature and develop evidence summary Develop rating form Expert panel completes pre-meeting ratings (first-round) Analyze and develop consensus statements Expert panel repeats ratings (second-round) RAND/UCLA modified Delphi panel
- 9. Mean scores of severity
- 10. © 2022 10 Panel output
- 11. Thank you for participating! CLICK HERE to learn more and watch the webinar